Introduction
Diabetes mellitus (DM), characterized by chronic hyperglycemia, is a major health concern in the aging population. The number of DM patients increases with the age of the patients. Approximately 26% of patients over 65 years old have DM, and this proportion is expected to increase rapidly in the coming decades (American Diabetes A., 2016) . Consequently, DM has become a major health care problem and a heavy social burden worldwide. DM is associated with various conditions that may influence cognitive function, such as hyperglycemia, hyperlipidemia, and obesity. A previous systematic review demonstrated that DM is a risk factor for mild cognitive dysfunction and dementia (Biessels et al., 2006; Cheng et al., 2012; Cukierman et al., 2005) . Older adults with DM have a higher risk of cognitive impairment and allcause dementia than that of other older adults (Mayeda et al., 2015; Sinclair et al., 2012) . However, recent literature has emerged that offers contradictory findings about cognitive outcomes in relation to blood glucose control (Launer et al., 2011) . The pathogenesis underlying the development of cognitive impairment in older adults with DM has not been established.
The interaction between the pathogenesis of DM and the active innate immune system and chronic subclinical inflammation has been reported previously (Pickup, 2004) . Hyperglycemia is linked with an enhanced inflammatory response (Fukuhara et al., 2007) . Individuals exhibit inflammatory features a few years before they are diagnosed with DM (Duncan et al., 2003) . In DM patients, second-rate inflammation is evidenced by higher levels of several inflammatory cytokines, such as C-reactive protein (CRP), in the plasma (Wang et al., 2013) . Basic studies in recent years have demonstrated that inflammatory cytokines have a considerable impact on the pathogenesis of cognitive decline in DM (Chung et al., 2015; Fei et al., 2015) . In addition, the relationship between serum levels of inflammatory cytokines, cognitive impairment and the risk of dementia in older adults has been verified in epidemiologic studies (Schmidt et al., 2002; Yaffe et al., 2003) . However, the potential mechanisms linking the innate immune system and inflammation with cognitive impairment in geriatric DM remain to be elucidated.
Inflammatory cytokines, such as CRP, are recognized by infiltrating and resident cells through specific receptors for the Fc region of immunoglobulin G (FcγRs) (Marnell et al., 2005; Takai, 2005) . In mice, monkeys, humans and other mammalian species, the FcγR family includes several activating members (FcγRI/CD64, IIA/CD32A, IIC/ CD32C (expressed by some individuals), IIIA/CD16A, and IIIB/CD16B in humans; FcγRI/CD64, III/CD16, and IV/CD16-2 in mice) and one inhibitory member (FcγRIIB/CD32B) (Pincetic et al., 2014; Quast et al., 2017) . The activating members (FcγRI, FcγRIII, and FcγRIV) are associated with the immunoreceptor tyrosine-based activation motif (ITAM) and, upon ligand binding with the phosphorylation of the ITAM sequence and the activation of spleen tyrosine kinase (SYK), resulting in phagocytosis, oxidative burst, cytokine/chemokine release, and antibody-dependent cellular cytotoxicity (ADCC) (Nimmerjahn and Ravetch, 2007) . Conversely, FcγRIIB contains the immunoreceptor tyrosine-based inhibition motif (ITIM) and abrogates cell activation and antibody production (Espeli et al., 2016; Li et al., 2014) . FcγRs are expressed widely on immune cells, including neutrophils, monocytes, macrophages (Nimmerjahn and Ravetch, 2006; Nimmerjahn and Ravetch, 2007) , and tissue resident cells, including glomerular mesangial cells (Abdelsamie et al., 2011) , neurons, microglia, astroglia and oligodendrocytes (Bouras et al., 2005) .
Altered FcγR expression has been found in DM patients and experimental models (Inoue et al., 2007; Restrepo et al., 2014) . On the other hand, the upregulation of activating FcγRs contributes to the development of learning and memory impairments in mice (FernandezVizarra et al., 2012) . This study therefore aimed to assess the latent role of FcγRs in the mechanism of cognitive impairment in geriatric DM with a model of DM.
Experimental procedures
2.1. Aged rats with DM induced by STZ DM was induced by streptozotocin (STZ, Sigma Co. USA) in aged Wistar rats by a procedure adapted from the one used by Kamal et al. (2000) . Rats with a blood glucose level > 16.7 mmol/l were diagnosed with DM. DM was induced in 36 aged Wistar rats. The diabetic rats were allocated to one of three subgroups: DM (no treatment), DM+0 (sham knockdown, DM+empty vector) and DM+shRNA (treated, DM +short hairpin RNA). There were 12 rats in each subgroup. Thirteen animals, 5 from the DM group, 4 from the sham knockdown group and 4 from the treated group, died before the last assessment. Thus, the DM group had 7 rats, and the DM+shRNA group had 8 rats. Moreover, 18 Wistar rats of the same age were treated with sodium citrate buffer (rather than STZ) to serve as age-matched controls. Similar to the diabetic rats, the control rats were divided into three subgroups: Con (control), Con+0 (sham knockdown, Con+empty vector) and Con +shRNA. There were 6 rats in each subgroup. Four animals, 1 from the Con group, 1 from the Con+0 group, and 2 from the Con+shRNA group, died before the last assessment. Thus, the Con group had 5 rats, and the Con+shRNA group had 4 rats. The rats were housed on sawdust in a stable environment (maintained at 22 ± 1°C with a 12-h light/dark cycle) with food and water available ad libitum. After the cognitive function of the rats was measured, the rats were sacrificed by decapitation, and their brains were rapidly removed from the skull for the dissection of the hippocampus. The experimental protocol was authorized by the Animal Experimentation Ethics Committee at The Sichuan University.
FcγRIV-shRNA constructs and lentiviral vector production
The rat FcγRIV mRNA sequence (NM_144559.2) was obtained from the NCBI website. The SYK-binding region was deleted to produce the FcγRIV-SYK(Δ)sequence. The target gene sequences were then subcloned into the region between the BamHI and EcoRI restriction sites of the pGMLLV-SC1 vector (element sequence: PRE-CMV-EGFP-PGK). After amplification, the clone was confirmed by sequencing (ZixinChem, China). Afterward, the purified plasmids were inserted into a lentiviral vector (ZixinChem, China) and used for transfection. A green fluorescent protein (GFP) tag was used to conveniently detect the lentiviral vectors in neurons. The vectors were prepared for transfection into 293 T cells as previously reported by Jessberger et al. (2009) . Viral particles were gathered and concentrated to achieve a titer of 1 × 10 10 transducing units (TU)/ml or more. Glycerol (8%) was required for long-term storage during plasmid preparation with respect to the animal experiments as previously recorded (Dreyer, 2011) .
Stereotaxic surgery
FcγRIV gene expression was knocked down in the hippocampal cornu ammonis area 1 (CA1) region of the rats five days after STZ injection. Pentobarbital sodium (1%, Sigma) was used to anesthetize the animals at a dose of 40 mg/kg. The lentivirus expressing FcγRIV-shRNA was injected at the following coordinates, according to the rat brain atlas: 3-4 mm posterior to bregma, 2.8-3 mm lateral to the midline, and −3 to −5 mm ventral to the dorsal surface of the skull (Khazipov et al., 2015) . An equal dose of the lentivirus containing no FcγRIV-shRNA was injected into the rats in the sham knockdown group. The viral suspension was injected according to the conceptual framework reported by Kirby et al. (2012) .
Measurement of blood glucose and body weight
Fasting (6 h) blood glucose was determined before DM induction (week 0) and after disease induction (weeks 2, 4 and 8) with a portable glucometer (LifeScan blood glucose meter, USA). At the same time points, the body weight of each rat was also evaluated.
Morris water maze (MWM) test
The cognitive function of the rats was assessed by the MWM test (a test of hippocampal-dependent spatial learning and long-term memory) (Morris, 1984; Frick et al., 1995) , which consisted of a 5-day training protocol (visible and invisible platform training sessions) as previously reported (Fei et al., 2015) . The position of the rat in the pool was automatically tracked by a video computer system (developed by the Institute of Materia Medica, Chinese Academy of Medical Sciences). The device provided the latency time to reach the platform and the swimming distance for each rat.
Hematein/eosin staining in the hippocampus and transmission electron microscopy (TEM)
The rats were sacrificed by decapitation, and the brains were rapidly removed from the skull for the dissection of the hippocampus. Changes in hippocampal morphology were examined with hematoxylin and eosin staining. The ultrastructure of the tissue samples was examined as previously reported by Schmalbach et al. (2015) . Synaptic ultrastructure changes in the hippocampus were observed with TEM (FEI TECNAI-G2, F20 S-TWIN, USA). Stereological techniques were used to measure the spine density (Xiao et al., 2016) .
Cell culture
The rat chromaffin cell-derived PC12 cell line was purchased from Shanghai Institute of Biochemistry and Cell Biology and cultured as previously described (Fei et al., 2015) . After the elimination of fetal calf serum for 24 h, the PC12 cells were stimulated with a normal concentration of D-glucose (5.5 mmol/l) or a high concentration of glucose (35 mmol/l) for up to 72 h. For inhibitory experiments, the cells were pretreated for 1 h with an antibody blocking FcγRI and FcγRIII (R&D Systems, USA) before high glucose treatment. For knockdown experiments, 60 pM of a small interfering RNA (FcγRIV or scramble) (Thermo Fisher, USA) was added to the culture medium to transfect the cells. The knockdown efficiency was evaluated by real-time PCR 24 h after transfection and was found to be 68.5 ± 0.6% (n = 3).
Real-time PCR
Total RNA from the hippocampus and the cells was extracted using Trizol (Invitrogen Co., USA) and cDNA was synthesized according to the manufacturer's instructions. Real-time PCR was performed according to the instructions of the SYBR® PrimerScriptTM RT-PCR Kit (TAKARA, China) and as previously described (Fei et al., 2015) . The primers for rat FcγRI, FcγRIII, FcγRIV, interleukin-6 (IL-6), tumor nuclear factor-α (TNF-α) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA have been reported elsewhere (Fernandez-Vizarra et al., 2012; Huang et al., 2008) . The housekeeping gene GAPDH was used as an internal control. The expression of each mRNA was normalized to GAPDH and is expressed as the mean ± standard errors of Q. Yue, et al. Experimental Gerontology 125 (2019) 110660 the mean (SEM).
Western blot
For Western blot, Nonidet P-40 (NP-40) solution was used to extract protein from the hippocampus as previously described (Sahin et al., 2013) . Protein expression was normalized to GAPDH and is expressed as the mean ± SEM.
Statistics
The data are expressed as the mean ± SEM. All analyses were carried out using SPSS, Version 21.0. One-way ANOVA was used and followed by an appropriate post hoc least significant difference comparison test. A value of P < 0.05 was considered statistically significant.
Results

Expression of FcγR isoforms in aged rats in the diabetic and control groups
Given that the expression of ITAM-FcγRs (FcγRI, III and IV) is upregulated in the kidneys of DM mice (Lopez-Parra et al., 2012), we examined whether experimental hyperglycemia alters ITAM-FcγR expression in the hippocampus of DM aged rats. As shown in Fig. 1 , the expression of activating FcγRs was increased at the mRNA level in the hippocampus of the diabetic animals, consistent with the changes seen in the kidneys of diabetic animals. The primary isoform exhibiting an increased expression level was FcγRIV (IV > I ≈ III).
Effect of FcγRIV-shRNA on blood glucose and body weight
High blood glucose levels (16.9-19.7 mmol/l) were present in the rats with STZ-induced DM. Treatment with FcγRIV-shRNA had no significant effect (P > 0.05) on blood glucose levels or body weight in DM and non-DM animals, as shown in Tables 1 and 2 , respectively. From the data in Table 2 , the body weight of DM rats decreased gradually with duration. These results were in accordance with a previous report (Kamal et al., 2000) .
Effects of FcγRIV-shRNA on cognitive impairment induced by DM
The MWM test is the main method used to measure the spatial learning and memory capacity of rats. The performance of the rats on this test was not significantly impacted by STZ or stereotaxic surgery. The differences in the mean escape latency (Fig. 2a) and the distance swum to reach to the hidden platform (Fig. 2c) between the different groups were not significant in the initial stage of DM induction. In the 7 weeks after surgery (the 8 weeks after STZ injection), the mean escape latency of the DM rats and the distance they swam to reach the hidden platform were significantly higher than those of the control animals on the last 3 days of the testing protocol (both p < 0.01, Fig. 2b, d) . Meanwhile, the DM aged rats treated with shRNA exhibited shorter mean escape latencies and distances swum to reach the hidden platform than those of the untreated DM animals (day 4-5: latencies: p < 0.05; distance: p < 0.05). In addition, no significant differences in the behavioral tests were evident among the subgroups of the control group. The aged rats in all groups behaved similarly in the visible platform test (data not shown). These observations suggest that sensorimotor function is unaffected in aged rats with STZ-induced DM.
3.4. The effect of viral-mediated FcγRIV knockdown on the levels of proinflammatory cytokines (IL-6, TNF-α) in the hippocampus
To assess the efficiency of the hippocampal-specific knockdown of FcγRIV in vivo, real-time PCR was performed to determine the expression of FcγRIV in the hippocampus. Fig. 3a provides the experimental data of FcγRIV mRNA expression in the hippocampus in the rats from the different groups. FcγRIV-shRNA significantly reduced the expression of FcγRIV mRNA in the hippocampus of DM aged rats. The expression of FcγRIV mRNA was not affected by stereotaxic surgery alone. Since inflammation plays a key role in the progression of diabetic Q. Yue, et al. Experimental Gerontology 125 (2019) 110660 complications (such as cognitive impairment) (Chung et al., 2015; Fei et al., 2015) , we examined the expression of pro-inflammatory cytokines such as IL-6 and TNF-α. As seen in Fig. 3b and c, it is apparent that the expression levels of IL-6 and TNF-α as measured by real-time PCR analysis were noticeably different in the DM aged rats and the controls (p < 0.05). All of these changes in pro-inflammatory cytokine expression were significantly attenuated in the FcγRIV-shRNA treatment group (p < 0.05, Fig. 3b, c ). FcγRIV-shRNA had no effect on the expression of IL-6 and TNF-α in the control rats (Fig. 3b, c) .
Effect of FcγRIV knockdown on nuclear factor κB (NF-κB) signaling in the hippocampus
Then, the signaling mechanism of ITAM-FcγRs that leads to the exacerbation of diabetic cerebral injury was investigated. Data from several studies have suggested that the activated NF-κB signaling pathway plays a pathogenic role in cognitive impairment in diabetic animals (Kuhad et al., 2009; Datusalia and Sharma, 2016) . The relationship between cognitive impairment and enhanced activation of this pathway was also observed in the present study. Western blot analysis revealed that the phosphorylation level of the NF-κB/p65 subunit in the hippocampus of DM aged rats was significantly increased (P < 0.05). FcγRIV-shRNA significantly diminished the elevated level of NF-κB/p65 in the hippocampus (P < 0.05). As Fig. 4 shows, no significant difference between the control group and the control +shRNA group was evident (p = 0.315). The difference between the DM group and the DM+0 group was also nonsignificant (p = 0.973).
Hematoxylin and eosin staining (HE)
The morphology of the hippocampal pyramidal cell layer was altered due to hyperglycemia (in the DM group), these alterations included a disordered cell arrangement and a decrease in the number of neurons (Fig. 5) . The knockdown FcγRIV partially restored the morphology of the neurons in the hippocampus of DM aged rats (Fig. 5) .
Ultrastructural changes in the hippocampal tissue
The synaptic ultrastructure of the hippocampus was observed by electron microscopy. The loss of synapses was evident in the Q. Yue, et al. Experimental Gerontology 125 (2019) 110660 hippocampal CA1 region of the DM rats compared with that of the control rats (p < 0.01, Fig. 6 ). After treatment with FcγRIV shRNA, the number of synapses in the DM rats increased significantly (p < 0.05, Fig. 6 ).
Effects of ITAM-FcγRs inhibition on the upregulation of proinflammatory cytokines (IL-6, TNF-α) caused by high glucose in PC12 cells
The role of ITAM-FcγRs in hyperglycemia-associated pathology was further studied in PC12 cells under ambient high glucose conditions. As shown in Fig. 7 , real-time PCR revealed that a high glucose concentration stimulated PC12 cells to produce a low-grade inflammatory response. This finding was confirmed by the elevated levels of pro-inflammatory cytokine (IL-6, TNF-α) mRNA expression (P < 0.05). FcγRIV small interfering RNA (siRNA) and/or a FcγRI-and FcγRIII-neutralizing antibody significantly blocked IL-6 (Fig. 7a ) and TNF-α (Fig. 7b ) expression in PC12 cells under ambient high glucose conditions (P < 0.05). The neurons were normal in the con group. Abbreviations: Con: non-DM control; DM: diabetes; DM+shRNA: diabetes+FcγRIV-shRNA. Fig. 6 . Effects of FcγRIV knockdown on the synaptic ultrastructure of the hippocampus by electron microscopy. Morphologically intact synapses (arrows) are displayed. High blood glucose led to swollen axons and a sharp decline in synapse density at 8 weeks after STZ injection in the DM group. Spine density was quantified by a stereological technique using Disector Countor, version 1.0, and is expressed as the mean ± SEM of the rats from each group (n = 4-8). ( ⁎⁎ P < 0.01 vs. Con; # P < 0.05 vs DM). Abbreviations: Con: non-DM control; DM: diabetes; DM+shRNA: diabetes+FcγRIV-shRNA.
Q. Yue, et al. Experimental Gerontology 125 (2019) 110660 3.9. Effects of ITAM-FcγRs blockage on excessive activation of NF-κB signaling pathway in cultured PC12 cells under ambient high glucose Fig. 4 shows that hyperglycemia was relevant to NF-κB signaling pathway activation in our diabetic animal model. As shown in Fig. 8 , a high glucose concentration led to a significant increase in sustained NF-κB activation, which was manifested by the phosphorylation of the NF-κB/p65 subunit in PC12 cells (P < 0.01). FcγRIV siRNA and/or a FcγRI-and FcγRIII-neutralizing antibody significantly attenuated the phosphorylation level of the NF-κB/p65 subunit in PC12 cells under ambient high glucose conditions (P < 0.05, Fig. 8 ).
Discussion
The present study was designed to investigate the effects of activating FcγRs (FcγRI, III and IV) on the cognitive function of aged rats with STZ-induced DM. One interesting finding was that the genetic expression of all of the activating ITAM-FcγRs isoforms (mainly FcγRIV, IV > I ≈ III) was markedly increased in the hippocampal tissue of DM aged rats (Fig. 1) . Another important finding was that the DM aged rats exhibited longer escape latencies and longer swimming distances in the MWM test than those of the control rats. These results are in line with those of previous reports (Fei et al., 2015; Fernandez-Vizarra et al., 2012; Kamal et al., 2000) . The decreased performance of the DM aged rats is viewed as a reflection of an impaired understanding of the task and a difficulty in learning the position of the platform. Since differences in mean escape latency and swimming distance in the MWM test were not found among the different groups within one week of STZ injection (Fig. 2a, c) , the differences were probably not caused by a direct toxic effect of STZ in the brain. To evaluate the role of FcγRIV directly, the activating FcγR observed to be induced the greatest in vivo and in vitro, we performed an experiment involving the knockdown of FcγRIV. The results of this study showed that the knockdown of FcγRIV in the hippocampus of the DM aged rats (the DM+shRNA group) resulted in a lessening of cognitive dysfunction and fewer pathological ultrastructure changes compared with those of the other two subgroups of DM rats (the DM and DM+0 groups). Hence, it can conceivably be hypothesized that ITAM-FcγRs (especially FcγRIV, which is highly Q. Yue, et al. Experimental Gerontology 125 (2019) 110660 similar to human FcγRIIIA (Nimmerjahn and Ravetch, 2006) ) promote the progression of cognitive impairment in older adults with DM. We then explored the mechanisms by which ITAM-FcγR isoforms exacerbate cognitive dysfunction in DM aged rats. In previous studies, altered FcγR expression was found in diabetic patients and experimental models (Inoue et al., 2007; Restrepo et al., 2014) . Bouras et al. reported that FcγRs are localized to neurons, microglia, astroglia and oligodendrocytes (Bouras et al., 2005) . van der Kleij et al. further demonstrated that neurons express functional Fc receptors (including FcγRIV) (van der Kleij et al., 2010) . Since the hippocampus is a brain structure that deals with specific learning and memory (Bunsey and Eichenbaum, 1996) and is especially susceptible in Alzheimer's disease (Lazarov and Hollands, 2016; Mu and Gage, 2011) , FcγRIV-shRNA lentiviral vectors were transfected into the hippocampus by stereotaxic surgery. The purpose of this procedure was to obtain the brain-specific knockdown of the target gene in the rats. Real-time PCR verified the efficiency of FcγRIV knockdown in the hippocampus and showed that FcγRIV-shRNA significantly abolished FcγRIV gene expression at the mRNA level in the hippocampus of the DM aged rats (Fig. 3A) . There was no evidence that stereotaxic surgery itself had an influence on the expression of FcγRIV.
The spatial memory of the rats in the MWM test was normal before surgery. However, the performance of the untreated DM aged rats in the MWM test seven weeks after surgery was inferior to that of the DM rats treated with shRNA and that of the control rats ( Fig. 2c and d ). This finding is not only in agreement with the level of FcγRIV expression in each group (Fig. 3a) but also with the behavioral and cognitive changes reported in a previous study (Alvarez et al., 2009 ). These results suggest that the deterioration of temporal memory and learning ability that result from the continuous exposure to hyperglycemia (Orduna et al., 2011) along with the decline of FcγRIV in the brain, is markedly relieved. Additionally, in the hippocampal CA1 region of the DM aged rats, the decrease in FcγRIV expression ameliorated cell morphologic changes, such as neuronal loss and disarrangement (Fig. 5) , and pathological ultrastructure changes, such as a decrease in the number of synapses (Fig. 6) . As synapses are highly specialized connections between two neurons and are essential for functional connections and signal transmission between neurons (Williams et al., 2010; Zeltser et al., 2012) , the low level of FcγRIV expression in DM rats is favorable for the homeostatic regulation of synaptic functions.
It is well known that inflammation plays a vital role in the pathogenesis of diabetic complications, including cognitive impairment (Gorska-Ciebiada et al., 2015; Takeda et al., 2010) . The pro-inflammatory cytokines (IL-6 and TNF-α) that lead to alterations in the neuronal microenvironment seem to be principal factors in the development of memory-related disorders (Yirmiya and Goshen, 2011) . IL-6 and TNF-α have detrimental effects on long-term potentiation and memory formation under inflammatory conditions. Our experimental results indicate that the levels of IL-6 and TNF-α expression in the hippocampus of DM aged rats are significantly higher than those in non-DM aged rats (Fig. 3b) , a difference that is mediated by an NF-κB-dependent mechanism. This finding is consistent with previous studies (Datusalia and Sharma, 2016; Fei et al., 2015) . Inflammation mediated by aggravated NF-κB expression has been associated with impairments in learning and memory and with other behavioral disorders (Ohta et al., 2014; Snow et al., 2014) . The present results also illustrate that the knockdown of FcγRIV notably attenuates the elevated expression of the IL-6 and TNF-α genes (Fig. 3b) and the NF-κB/p65 protein in the hippocampus of diabetic aged rats (Fig. 4) . The results also suggest that the inhibition of ITAM-FcγRs in the hippocampus diminishes the inflammatory response that results from continuous hyperglycemia.
In vitro, low-grade inflammation was confirmed by the excessively activation of the NF-κB signaling pathway in PC12 cells cultured with high glucose. The characteristics of low-grade inflammation were elevated levels of the NF-κBp65 protein (Fig. 8) and pro-inflammatory cytokines (IL-6, TNFα) (Fig. 7) . Inhibition experiments were executed with FcγRIV siRNA and/or a FcγRI-and FcγRIII-neutralizing antibody. The results showed that blocking the expression of ITAM-FcγRs significantly eliminated the inflammatory responses caused by high glucose in cultured PC12 cells (Figs. 7, 8) . This finding is similar to that of our previous studies in HK-2 cells cultured with high glucose (Liu et al., 2011) . Combining this evidence with our related results in vivo and in vitro, we speculated that the mechanism by which ITAM-FcγRs promote cognitive impairment in DM and aging may be the enhancement of the NF-κB signaling pathway and the upregulation of inflammatory cytokines (IL-6, TNFα) in the hippocampus.
In summary, our current work ventured to explore the effects of ITAM-FcγRs on learning and memory in geriatric DM. The findings demonstrate that increased ITAM-FcγR activity in the brains of DM aged rats impaired learning and memory function. The inhibition of ITAM-FcγRs significantly improves learning and memory function in DM aged rats. Although the specific mechanism of ITAM-FcγRs on the cognitive impairment of DM aged rats requires further examination, these results suggest that ITAM-FcγRs can be viewed as a potential target for preventing cognitive impairment in older adults with DM. Consequently, strategies targeting ITAM-FcγR activity may slow cognitive impairment onset and progression. In the future, ITAM-FcγR activity in older adults with DM may have the potential to serve as an early biomarker of cognitive impairment.
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